Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psilocybin
psilocybin
Incannex says psilocybin therapy lowered anxiety in small study
BioPharma Dive
Wed, 02/28/24 - 09:40 pm
Icannex
psilocybin
clinical trials
generalized anxiety disorder
Compass shows safety in first psilocybin trial for PTSD, but efficacy data still to come
Fierce Biotech
Wed, 12/20/23 - 09:30 am
Compass Therapeutics
clinical trials
psychedelic drugs
PTSD
psilocybin
Tryp to initiate psilocybin-assisted psychotherapy trial to treat IBS
Clinical Trials Arena
Fri, 07/14/23 - 10:01 am
Tryp Therapeutics
clinical trials
IBS
psilocybin
Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder
BioSpace
Wed, 07/6/22 - 10:48 am
Clairvoyant Therapeutics
clinical trials
psilocybin
alcohol-use disorder
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
Stat
Tue, 11/9/21 - 11:37 pm
psychedelic drugs
psilocybin
treatment-resistant depression
COMPASS Pathways
clinical trials
First-of-its-kind study pits psilocybin against a common antidepressant
Stat
Wed, 04/14/21 - 09:45 pm
psilocybin
psychedelic drugs
depression
antidepressants
Compass raises $80M to take magic mushroom drug toward phase 3
Fierce Biotech
Mon, 04/27/20 - 09:25 am
COMPASS Pathways
psilocybin
magic mushrooms
treatment-resistant depression
In a key step for psychedelic research, magic mushroom compound clears first clinical safety hurdle
Endpoints
Thu, 12/12/19 - 05:35 pm
antidepressants
COMPASS Pathways
psilocybin
FDA tags psilocybin drug as clinical depression Breakthrough Therapy
Pharmaforum
Mon, 12/2/19 - 09:46 am
FDA
psilocybin
major depressive disorder
Usona
PSIL201
Psilocybin Therapy for Treatment-Resistant Depression is Being Taken Seriously by Regulators as FDA Gives Go-Ahead to Clinical Trial
Xtalks
Fri, 08/24/18 - 11:03 am
COMPASS Pathways
FDA
psilocybin
treatment-resistant depression